SterisMEX:STE N 90 Days Payable is 31.92 as of Mar. 2026, which is 1% below its 10-year median of 32.22. GuruFocus rates MEX:STE N with a GF Score™ of 90/100 and a GF Value™ of MXN4,960.30. The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, Steris ranks worse than 81.89% on this metric.
Steris's average Accounts Payable for the
three
months ended in Mar. 2026 was MXN5,621 Mil. Steris's Cost of Goods Sold for the
three
months ended in Mar. 2026 was MXN16,073 Mil.
Hence, Steris's Days Payable for the
three
months ended in Mar. 2026 was 31.92.
The historical rank and industry rank for Steris's Days Payable or its related term are showing as below:
MEX:STE N'
s Days Payable Range Over the Past 10 Years
Min: 29.84 Med: 32.22 Max: 34.99
Current: 33.41
During the past 13 years, Steris's highest Days Payable was 34.99. The lowest was 29.84. And the median was 32.22.
MEX:STE N's Days Payable is ranked worse than 81.89% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs MEX:STE N: 33.41
Steris's Days Payable
increased
from Mar. 2025 (28.47) to Mar. 2026 (31.92).
It may suggest that Sterisdelayed paying its suppliers.
Steris Days Payable Related Terms
Steris Days Payable Historical Data
* Premium members only.
The historical data trend for Steris's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:STE N vs ZBH, GEHC, DXCM: Days Payable Comparison
For the Medical Devices subindustry, Steris's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Days Payable distribution charts can be found below:
* The bar in red indicates where Steris's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Steris's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (MEX:STE N) has a Days Payable of 31.92 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Steris and its competitors. This is near median its historical median of 32.22. Over the past decade, Steris' Days Payable has ranged from 29.84 to 34.99. According to the industry distribution chart, Steris ranks #651 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 81.9%.
Is Steris' Days Payable too high?
Steris' current Days Payable of 31.92 is near median its 10-year median of 32.22. Over the past 10 years, this metric has ranged from a low of 29.84 to a high of 34.99. The Medical Devices & Instruments industry median Days Payable is 67.87. Steris' value of 31.92 is 53% below this industry median. Based on the distribution chart, Steris ranks #651 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Steris has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Steris' Days Payable compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #651 out of 795 companies for Days Payable. This places Steris in the lower half of its industry. The industry median Days Payable is 67.87. Steris' value of 31.92 is 53% below this benchmark. Historically, Steris' own Days Payable has ranged from 29.84 to 34.99 over the past decade. While the company's 10-year median is 32.22 vs. the industry median of 67.87, Steris has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Steris's current Days Payable of 31.92 is 53% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Steris and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current Days Payable is 31.92, which is near median its own 10-year median of 32.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (MEX:STE N) has a current Days Payable of 31.92. The stock's GF Value™ is MXN4,960.30, compared to a current price of MXN3,824.43 — trading 22.9% below its estimated fair value. The current Days Payable is 31.92, which is near median its 10-year median of 32.22 and 53% below the Medical Devices & Instruments industry median of 67.87. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Steris (MEX:STE N), the current Days Payable is 31.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Steris (MEX:STE N) Overvalued in 2026?
Based on GuruFocus' analysis, Steris stock appears to be undervalued.
The current stock price of MXN3,824.43 is trading 22.9% below its estimated GF Value™ of MXN4,960.30.
Key valuation signals for MEX:STE N:
Days Payable: 31.92 (near median its 10-year median of 32.22)
GF Value™: MXN4,960.30 vs. price of MXN3,824.43 (22.9% below fair value)
Industry Position: 53% below the Medical Devices & Instruments median (#651 of 795)
No single metric tells the full story. See the MEX:STE N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score
Get the complete analysis for MEX:STE N
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STE N has been successfully added to your 
